Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Oncimmune Holdings plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Aug 2025 | $6.90M | $6.90M - $6.90M | -$6.90M | $0.002 | 1 |
| Aug 2024 | $2.80M | $2.80M - $2.80M | -$4.07B | -$0.043 | 1 |
| Aug 2023 | $17.95M | $17.95M - $17.95M | -$856.83M | $0.043 | 1 |
| Aug 2022 | $15.53M | $15.53M - $15.53M | -$175.18M | $0.026 | 1 |
| Aug 2021 | $12.09M | $12.09M - $12.09M | -$189.59M | -$0.004 | 1 |
| Aug 2020 | $5.61M | $5.61M - $5.61M | -$22.62M | -$0.077 | 1 |
| Aug 2019 | $715.0K | $715.0K - $715.0K | -$715.0K | -$0.134 | 1 |
| Aug 2018 | $1.50M | $1.50M - $1.50M | -$1.50M | -$0.156 | 1 |
| Aug 2017 | $200.0K | $200.0K - $200.0K | -$200.0K | -$0.114 | 1 |
| Aug 2016 | $500.0K | $500.0K - $500.0K | -$500.0K | -$0.124 | 1 |